Aethlon Medical Inc (AEMD)

US · Healthcare · Medical Devices

—

Latest quarter · ended 2026-06-30

Net profit

$-1.5M

EPS

$-4.02

EPS estimate

$-4.05

EPS came in at -4.02 against a street estimate of -4.05 — a beat of 0.7%.

Market cap

$1.0M

Forward P/E

0.2

P/B

0.21

Book value

$10.89

EPS (TTM)

$-13.98

52-week high

$41.35

52-week low

$1.41

50-day MA

$2.78

200-day MA

$9.52

Beta

1.40

Analysts rate Aethlon Medical Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $13.25.

Insiders

0.58%

Institutions

4.34%

Fund	Stake
Geode Capital Management, LLC	0.75%
Ikarian Capital, LLC	0.44%
Shay Capital LLC	0.43%
XTX Topco Ltd	0.41%
Morgan Stanley - Brokerage Accounts	0.06%
Tower Research Capital LLC	0.05%
UBS Group AG	0.03%
Group One Trading, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aethlon Medical Inc — free to start.

Data updated 2026-09-18.